Research News for January 2010
1–6 of 6 articles
-
FDA Approves Tykerb-Femara Combo to Treat Advanced-Stage Disease
The FDA has approved the combination of Tykerb and Femara to treat post-menopausal women diagnosed with hormone-receptor-positive, HER2-positive advanced-stage breast cancer.
-
Herceptin Plus Chemo Before Surgery Better Than Chemo Alone for HER2-Positive Locally-Advanced Disease
Research suggests that giving Herceptin at the same time as chemotherapy BEFORE surgery for HER2-positive locally advanced or inflammatory breast cancer can lengthen the time before the cancer comes back or grows compared to chemotherapy alone.
-
Digital Mammograms Offer Lower Radiation Exposure; Amount Varies
While digital mammograms generally expose women to less radiation, taking more than the standard four images (two of each breast) reduces this benefit.
-
Journal Commentaries Discuss Mammogram Recommendations
Commentaries in the Journal of the American Medical Association reviewed here offer various perspectives on some of the U.S. Preventive Services Task Force recommended changes to breast cancer screening guidelines.
-
Lymphedema Risk Seems to be Lowered by Physiotherapy
A small Spanish study found that physiotherapy can stop lymphedema from developing in some women after breast cancer surgery.
-
American College of Radiology Supports Starting Mammograms at 40
The American College of Radiology and the Society of Breast Imaging continue to support annual mammograms starting at age 40 and call for high-risk women to start screening by age 30.
1–6 of 6 articles
